In Friend murine erythroleukemia, the membrane glycoprotein (gp55) encoded by the spleen focus-forming virus (SFFV) env gene forms a disulfide-bonded dimer that binds to erythropoietin receptors (EpoR) to stimulate erythroblastosis. This mitogenic interaction is blocked in mice homozygous for the Fv-2r resistance allele and also in nonmurine species. Recently, we found that SFFV mutants with deletions in one domain (called ecotropic) of gp55 overcome Fv-2r resistance, suggesting that Fv-2r resistance is targeted against this domain. Thus, the SFFV glycoprotein structure optimal for activating EpoR depends on the mouse genetic background in a manner amenable to classic genetic analysis. Moreover, in contrast to gp55, these same partially deleted mutant glycoproteins activate human EpoR in a cell culture system, raising the possibility that Fv-2-related proteins may restrict SFFV not only in mice but also in other species. Evidence suggests that Fv-2 proteins may interact with EpoR as """"""""guardians"""""""", and that the efficiency of this defense depends on the structures of gp55, of polymorphic Fv-2 proteins, and of the species EpoR. We propose: (l) Determine whether SFFV mutants with deletions in the ecotropic domain cause erythroblastosis in nonmurine species, and identify the critical target sequence in gp55 for Fv-2-mediated host resistance. (2) One SFFV mutant (Pvu-delta) with such a deletion causes extensive erythroblastosis in both DBA/2 (Fv-2s) and in congenic D2.R16 (Fv-2r mice. However, Pvu- delta is surprisingly not pathogenic in several mouse strains that are susceptible to wild-type SFFV. By genetic crosses, identify mouse genes that restrict Pvu-delta but not wild-type SFFV. (3) It has been hypothesized that SFFV may have originated from a type of mouse retrovirus (called MCF) by a series of env mutations. Recently, we developed a means to isolate novel SFFVs. From a single mouse we isolated an unusual MCF that activates EpoR plus a series of intermediates in its evolution to form a new SFFV. Clone and sequence all of these viruses in order to definitively trace the SFFV lineage. Do SFFVs evolve differently in distinct genetic backgrounds? (4) Clone cDNAs for erythroblast proteins that bind to EpoR and determine their role(s) in controlling susceptibility to Friend erythroleukemia. (5) Determine whether EpoR-associated proteins contribute to human erythropoietic diseases. Friend erythroleukemia has been the principal model system for analyzing genetic control of cancer. Our background studies and understanding of the primary pathogenic mechanism now provides an opportunity to elucidate molecular mechanisms for host resistance to an oncoprotein and for regulation of hemopoietin receptors in normal and diseased animals.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA054149-09
Application #
2871755
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Cole, John S
Project Start
1991-04-01
Project End
2000-01-31
Budget Start
1999-02-01
Budget End
2000-01-31
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Marin, M; Tailor, C S; Nouri, A et al. (1999) Polymorphisms of the cell surface receptor control mouse susceptibilities to xenotropic and polytropic leukemia viruses. J Virol 73:9362-8
Tailor, C S; Nouri, A; Lee, C G et al. (1999) Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc Natl Acad Sci U S A 96:927-32
Siciliano, S J; Kuhmann, S E; Weng, Y et al. (1999) A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1. J Biol Chem 274:1905-13
Hoatlin, M E; Gomez-Lucia, E; Lilly, F et al. (1998) Origin and rapid evolution of a novel murine erythroleukemia virus of the spleen focus-forming virus family. J Virol 72:3602-9
Gomez-Lucia, E; Zhi, Y; Nabavi, M et al. (1998) An array of novel murine spleen focus-forming viruses that activate the erythropoietin receptor. J Virol 72:3742-50
Hoatlin, M E; Kabat, D (1995) Host-range control of a retroviral disease: Friend erythroleukemia. Trends Microbiol 3:51-7
Hoatlin, M E; Kozak, S L; Spiro, C et al. (1995) Amplified and tissue-directed expression of retroviral vectors using ping-pong techniques. J Mol Med 73:113-20
Hoatlin, M E; Ferro Jr, F E; Kozak, S L et al. (1994) A Friend virus mutant encodes a small glycoprotein that causes erythroleukemia. J Virol 68:4053-6
Ferro Jr, F E; Kozak, S L; Hoatlin, M E et al. (1993) Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus. J Biol Chem 268:5741-7
Kozak, S L; Hoatlin, M E; Ferro Jr, F E et al. (1993) A Friend virus mutant that overcomes Fv-2rr host resistance encodes a small glycoprotein that dimerizes, is processed to cell surfaces, and specifically activates erythropoietin receptors. J Virol 67:2611-20